Key result
Process-specific polygenic risk scores link to up to ~84% higher coronary event risk.
Why the study?
Standard polygenic risk scores capture overall genetic liability to coronary artery disease (CAD) but do not reveal the specific biological processes contributing to risk in an individual.
Does decomposing polygenic risk of coronary artery disease into eight process-specific polygenic risk scores (pPRSs) predict clinical coronary events and subclinical CAD across large biobank cohorts?
Cohort (n=537,657)
Yes
Does decomposing polygenic risk of coronary artery disease into eight process-specific polygenic risk scores (pPRSs) predict clinical coronary events and subclinical CAD across large biobank cohorts?
Decomposing polygenic risk for coronary artery disease into eight distinct biological pathways provides a biologically resolved genetic risk framework that consistently predicts clinical and subclinical coronary disease and may inform precision prevention.
Answers are grounded in this paper and cite their sources.
Process-specific CAD polygenic scores may refine risk stratification; leaves open clinical adoption pending prospective validation.
Standard polygenic risk scores capture overall genetic liability to coronary artery disease (CAD) but do not reveal the biological processes contributing to risk in an individual. Here, we applied data-driven latent factor decomposition to 526 genome-wide significant CAD-associated variants, using their associations with 78 CAD-related phenotypic traits. We identified eight genetic components corresponding to cholesterol-enriched lipoproteins, triglyceride-rich lipoproteins, lipoprotein(a), metabolically unhealthy normal weight, obesity, endothelial dysfunction, coagulation and cardiac remodeling. Process-specific polygenic risk scores (pPRSs) captured biological profiles beyond those reflected by conventional risk factors. In UK Biobank (n = 458,905), the Swedish CArdioPulmonary bioImage Study (n = 24,904) and Mass General Brigham Biobank (n = 53,848), pPRSs were consistently associated with clinical and subclinical CAD and showed distinct biomarker, proteomic and comorbidity profiles. These findings establish a framework for biologically resolved genetic CAD risk and may inform process-specific approaches to precision prevention.
No takes yet. Share an insight, caveat, or question.
Morze et al. (2026) conducted a cohort in Coronary artery disease (n=537,657). Process-specific polygenic risk scores (pPRSs) for coronary artery disease (highest decile, strongest component: Cardiac remodeling pPRS) vs. Lowest decile of each process-specific polygenic risk score was evaluated on Clinical coronary events (coronary artery disease) (OR 1.84, 95% CI 1.56-2.18). Eight process-specific polygenic risk scores for CAD were consistently associated with clinical coronary events and distinct subclinical phenotypes.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: